Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Morrison & Foerster advised Rakuten Medical, a clinical stage, global biotechnology company developing precision, cell-targeting therapies to treat cancer utilizing a proprietary photo-immunotherapy platform, in a carve-out asset acquisition of a key component of the mechanism of action for the company’s products from Li-Cor.

MoFo Advises Rakuten Medical on its Acquisition and Concurrent $90M Financing

About Morrison Forester

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison & Foerster advised Rakuten Medical, a clinical stage, global biotechnology company developing precision, cell-targeting therapies to treat cancer utilizing a proprietary photo-immunotherapy platform, in a carve-out asset acquisition of a key component of the mechanism of action for the company’s products from Li-Cor. The acquisition ensures a reliable supply chain to support the development and commercialization of therapies on Rakuten Medical’s Illuminox™ platform as the company embarks on global Phase 3 clinical trials for its lead product which has already received marketing approval in Japan.The MoFo team also advised Rakuten Medical on a concurrent $90 million convertible note financing. Rakuten Medical has raised over $560 million of capital to date.The MoFo team was led by San Diego corporate partners Jim Krenn and Jay de Groot, with significant assistance from San Francisco technology transaction partner Rufus Pichler and associate Leanne Ta, New York corporate associates Stephanie Ference and Lee Nisson, San Diego corporate associates Andrew Dixon and Carey Hughes, San Diego patent partner Jim Mullen and associate Huang Huang, Washington D.C. antitrust partner Vishal Mehta and associates Eric J. Olson and Haydn Forrest, San Francisco tax partner Maureen Linch and associates Adam Nguyen and Jessica Stern, San Diego tax partner Shane Shelley, Washington D.C. CFIUS of counsel Aki Bayz, FDA partner Bethany Hills, and others.Read more about the transaction in the company’s <a href="https://www.prnewswire.com/news-releases/rakuten-medical-inc-acquires-key-assets-and-manufacturing-technology-from-li-cor-biosciences-301204950.html?tc" target="_blank">press release</a>.

MoFo Advises Rakuten Medical on its Acquisition and Concurrent $90M Financing